Consolidated Statements of Operations (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Mar. 31, 2017	Mar. 31, 2016	Mar. 31, 2017	Mar. 31, 2016
REVENUES:
Contract revenue	$ 10,823,748	$ 0	$ 10,823,748	$ 0
OPERATING EXPENSES:
Research and development	9,062,316	10,676,342	28,422,975	32,546,363
General and administrative	4,773,696	1,409,406	7,289,342	3,965,460
Total operating expenses	13,836,012	12,085,748	35,712,317	36,511,823
Loss from operations	(3,012,264)	(12,085,748)	(24,888,569)	(36,511,823)
OTHER INCOME (EXPENSE):
Interest income	6,304	15,062	18,940	39,036
Interest expense	(558,702)	(625,832)	(1,777,222)	(1,883,334)
Total other income (expense), net	(552,398)	(610,770)	(1,758,282)	(1,844,298)
NET LOSS	$ (3,564,662)	$ (12,696,518)	$ (26,646,851)	$ (38,356,121)
Basic and diluted net loss per common share	$ (0.02)	$ (0.08)	$ (0.15)	$ (0.25)
Weighted average number of common shares outstanding used in computing basic and diluted net loss per common share	196,580,519	156,368,617	179,841,133	156,301,259